Mikkel Zahle OESTERGAARD

Follow

Person

Zollikon, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Obinutuzumab treatment of a DLBCL patient subgroup
- Patent number 11,597,772
- Issue date Mar 7, 2023
- Mikkel Zahle Oestergaard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP
- Publication number 20230348611
- Publication date Nov 2, 2023
- HOFFMANN-LA ROCHE INC.
- Mikkel Zahle OESTERGAARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTION AND CHARACTERIZATION OF DLBCL CELL OF ORIGIN SUBTYPES
- Publication number 20220056531
- Publication date Feb 24, 2022
- Genentech, Inc.
- Sally Elizabeth TRABUCCO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
OBINUTUZUMAB TREATMENT OF A DLBCL PATIENT SUBGROUP
- Publication number 20200317800
- Publication date Oct 8, 2020
- HOFFMANN-LA ROCHE INC.
- Mikkel Zahle OESTERGAARD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE